Healthcare Equipment and Supplies
Company Overview of Alcon Laboratories, Inc.
Alcon Laboratories, Inc. manufactures, markets and distributes eye care products. The company offers ophthalmic pharmaceuticals, surgical equipment, and contact lenses. Its products include ophthalmic solutions and suspensions, eye drops, otic suspensions, contact lens solutions, and eye vitamins. The company also offers contact lenses and surgical devices for cataract, glaucoma, vitreoretinal, and refractive treatment. The company was founded in 1945 and is based in Fort Worth, Texas. Alcon Laboratories, Inc. operates as a subsidiary of Alcon, Inc.
6201 South Freeway
Fort Worth, TX 76134-2099
Founded in 1945
Key Executives for Alcon Laboratories, Inc.
Senior Vice President of Global Manufacturing and Technical Operations
Senior Vice President, Chief Legal Officer, General Counsel, and Corporate Secretary
Senior Vice President of Human Resources
Senior Vice President of International Markets
Compensation as of Fiscal Year 2015.
Alcon Laboratories, Inc. Key Developments
Alcon Laboratories Inc. Wins $482.26 Million Federal Contract
Jun 26 15
Alcon Laboratories Inc. won a $482,262,480 federal contract from the U.S. Department of Veterans Affairs National Acquisition Center, Hines, Illinois, for drugs, pharmaceuticals and hematology related products.
A Prominent Fort Worth Resident Files $110 Million Gender Discrimination Suit Against Alcon Laboratris Inc
Mar 18 15
A Fort Worth resident filed a $110 million gender discrimination suit against Alcon Laboratris Inc. claiming the eye-care products company routinely denied female employees equal pay and promotion opportunities. Elyse Dickerson, wife of the curator at the Kimbell Art Museum, and Susan Orr, claim in the suit that Alcon has a "boy's club atmosphere" that's hostile to women. The new suit claims that 12 of 15 members of Alcon's executive leadership team are men, including the global head of Alcon, Jeff George, as well as the chief financial officer, all five region presidents and the senior vice president for human resources. Women make up fewer than 15% of vice presidents and senior directors in Novartis' Alcon division. A current Executive Leadership Team member repeatedly arranged for prostitutes to meet with doctors viewed by the company as "key opinion leaders" but was never disciplined or demoted for doing so, the suit says. Male senior leaders invited younger male employees to visit strip clubs, play golf, and drink at bars, but female employees were rarely invited, the lawsuit says. Dickerson and Orr say in the suit that the company violated the U.S. Equal Pay Act and Title VII of the Civil Rights Act of 1964, which prohibits gender discrimination by employers. Dickerson says in the suit that she was fired from her job as a global director for complaining about what she saw as inequities at the company. She is seeking $10 million and her job back. Orr, a research scientist, says the lack of promotions forced her to resign. She's seeking at least $100 million on behalf of a proposed class of thousands of Alcon employees who are women.
Fda Approves Alcon Laboratories, Inc.'s Xtoro to Treat Swimmer’s Ear
Dec 17 14
The U.S. Food and Drug Administration approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer's ear. Acute otitis externa is an infection in the outer ear and ear canal, usually caused by bacteria in the ear canal. Activities in which the ear is underwater can create a moist environment where bacteria may sometimes grow. The infection causes inflammation of the ear canal leading to pain, swelling, redness of the ear and discharge from the ear. Xtoro is an eardrop approved to treat acute otitis externa caused by Pseudomonas aeruginosa and Staphylococcus aureus. Xtoro is the newest drug belonging to the fluoroquinolone antimicrobial drug class to be approved by the FDA. It joins several other antibacterial drug products previously approved to treat ear infections. Xtoro is manufactured Alcon Laboratories, Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|